AdAlta and Carina Biotech to Develop Next-Generation CAR-T Cancer Therapeutics
Combining Carina’s advanced CAR-T platform technologies with AdAlta’s i-body targeting capability, the collaboration aims to create unique, next-generation bi-specific CAR-T cells. AdAlta Limited...